NO2987793T3 - - Google Patents
Info
- Publication number
- NO2987793T3 NO2987793T3 NO14786115A NO14786115A NO2987793T3 NO 2987793 T3 NO2987793 T3 NO 2987793T3 NO 14786115 A NO14786115 A NO 14786115A NO 14786115 A NO14786115 A NO 14786115A NO 2987793 T3 NO2987793 T3 NO 2987793T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013087151 | 2013-04-18 | ||
| PCT/JP2014/061007 WO2014171528A1 (ja) | 2013-04-18 | 2014-04-18 | ヘテロ環酢酸アミド化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2987793T3 true NO2987793T3 (pl) | 2018-03-24 |
Family
ID=51729480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO14786115A NO2987793T3 (pl) | 2013-04-18 | 2014-04-18 |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US8937087B2 (pl) |
| EP (1) | EP2987793B1 (pl) |
| JP (1) | JP6252582B2 (pl) |
| KR (1) | KR102193247B1 (pl) |
| CN (1) | CN105121435B (pl) |
| AR (1) | AR095883A1 (pl) |
| AU (1) | AU2014254768B2 (pl) |
| BR (1) | BR112015026512B1 (pl) |
| CA (1) | CA2909783C (pl) |
| CY (1) | CY1119754T1 (pl) |
| DK (1) | DK2987793T3 (pl) |
| EA (1) | EA028968B1 (pl) |
| ES (1) | ES2651866T3 (pl) |
| HR (1) | HRP20171786T1 (pl) |
| HU (1) | HUE036054T2 (pl) |
| IL (1) | IL241962B (pl) |
| LT (1) | LT2987793T (pl) |
| ME (1) | ME02891B (pl) |
| MX (1) | MX2015014646A (pl) |
| MY (1) | MY175971A (pl) |
| NO (1) | NO2987793T3 (pl) |
| NZ (1) | NZ713118A (pl) |
| PH (1) | PH12015502341B1 (pl) |
| PL (1) | PL2987793T3 (pl) |
| PT (1) | PT2987793T (pl) |
| RS (1) | RS56865B1 (pl) |
| SA (1) | SA515370015B1 (pl) |
| SG (1) | SG11201508448RA (pl) |
| SI (1) | SI2987793T1 (pl) |
| SM (1) | SMT201700594T1 (pl) |
| TW (1) | TWI625329B (pl) |
| UA (1) | UA116243C2 (pl) |
| WO (1) | WO2014171528A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR105025A1 (es) | 2015-06-19 | 2017-08-30 | Astellas Pharma Inc | Compuesto de imidazodiazepina |
| TWI725408B (zh) | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
| JP2022500412A (ja) | 2018-09-13 | 2022-01-04 | バイエル・アクチエンゲゼルシヤフト | 害虫防除剤としての複素環誘導体 |
| CN110590576A (zh) * | 2019-08-15 | 2019-12-20 | 安徽金禾实业股份有限公司 | 一种4-多氟代甲氧基邻苯二胺的制备方法 |
| CN114380709B (zh) * | 2021-12-31 | 2023-07-21 | 西北农林科技大学 | 4-氯-2-酰氨基酚的合成方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2674524B1 (fr) * | 1991-03-25 | 1993-05-21 | Adir | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| JP2002541151A (ja) * | 1999-04-02 | 2002-12-03 | ニューロゲン コーポレイション | アリールおよびヘテロアリール縮合アミノアルキル−イミダゾール誘導体：ＧＡＢＡａ受容体の選択的修飾物質 |
| US6627624B1 (en) | 1999-04-02 | 2003-09-30 | Neurogen Corporation | Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| US6380210B1 (en) | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| AUPQ309399A0 (en) | 1999-09-28 | 1999-10-21 | Fujisawa Pharmaceutical Co., Ltd. | Benzothiazoline derivatives |
| ATE450508T1 (de) | 2001-09-14 | 2009-12-15 | High Point Pharmaceuticals Llc | Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren |
| US7361671B2 (en) | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
| ATE486842T1 (de) * | 2002-03-12 | 2010-11-15 | Merck Sharp & Dohme | Substituierte amide |
| WO2004082605A2 (en) | 2003-03-14 | 2004-09-30 | Merck & Co. Inc. | Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| KR20060129023A (ko) * | 2004-02-23 | 2006-12-14 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 신규한 헤테로환 화합물 |
| ES2332597T3 (es) * | 2004-05-27 | 2010-02-09 | Ucb Pharma S.A. | Derivados de benzoxazolona, procedimientos para su preparacion y su uso. |
| US7790726B2 (en) | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
| WO2007044885A2 (en) | 2005-10-11 | 2007-04-19 | Chemocentryx, Inc. | Piperidine derivatives and methods of use |
| CL2007002097A1 (es) | 2006-07-20 | 2008-01-18 | Smithkline Beecham Corp | Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras. |
| US7786157B2 (en) | 2007-03-16 | 2010-08-31 | Chemocentryx, Inc. | OXO-imidazolidines as modulators of chemokine receptors |
| DE102007026341A1 (de) * | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
| GB0713686D0 (en) * | 2007-07-13 | 2007-08-22 | Addex Pharmaceuticals Sa | New compounds 2 |
-
2014
- 2014-04-16 AR ARP140101624A patent/AR095883A1/es active IP Right Grant
- 2014-04-17 TW TW103114022A patent/TWI625329B/zh not_active IP Right Cessation
- 2014-04-18 EP EP14786115.7A patent/EP2987793B1/en active Active
- 2014-04-18 KR KR1020157027691A patent/KR102193247B1/ko not_active Expired - Fee Related
- 2014-04-18 MX MX2015014646A patent/MX2015014646A/es active IP Right Grant
- 2014-04-18 MY MYPI2015703694A patent/MY175971A/en unknown
- 2014-04-18 HU HUE14786115A patent/HUE036054T2/hu unknown
- 2014-04-18 WO PCT/JP2014/061007 patent/WO2014171528A1/ja not_active Ceased
- 2014-04-18 HR HRP20171786TT patent/HRP20171786T1/hr unknown
- 2014-04-18 CA CA2909783A patent/CA2909783C/en active Active
- 2014-04-18 JP JP2015512531A patent/JP6252582B2/ja active Active
- 2014-04-18 SI SI201430479T patent/SI2987793T1/en unknown
- 2014-04-18 LT LTEP14786115.7T patent/LT2987793T/lt unknown
- 2014-04-18 BR BR112015026512-0A patent/BR112015026512B1/pt not_active IP Right Cessation
- 2014-04-18 PL PL14786115T patent/PL2987793T3/pl unknown
- 2014-04-18 NO NO14786115A patent/NO2987793T3/no unknown
- 2014-04-18 ME MEP-2017-277A patent/ME02891B/me unknown
- 2014-04-18 NZ NZ713118A patent/NZ713118A/en not_active IP Right Cessation
- 2014-04-18 UA UAA201511337A patent/UA116243C2/uk unknown
- 2014-04-18 US US14/256,135 patent/US8937087B2/en active Active
- 2014-04-18 SM SM20170594T patent/SMT201700594T1/it unknown
- 2014-04-18 CN CN201480020846.XA patent/CN105121435B/zh active Active
- 2014-04-18 AU AU2014254768A patent/AU2014254768B2/en not_active Ceased
- 2014-04-18 RS RS20171324A patent/RS56865B1/sr unknown
- 2014-04-18 PT PT147861157T patent/PT2987793T/pt unknown
- 2014-04-18 EA EA201591988A patent/EA028968B1/ru not_active IP Right Cessation
- 2014-04-18 ES ES14786115.7T patent/ES2651866T3/es active Active
- 2014-04-18 DK DK14786115.7T patent/DK2987793T3/en active
- 2014-04-18 SG SG11201508448RA patent/SG11201508448RA/en unknown
- 2014-10-28 US US14/525,982 patent/US9708307B2/en active Active
-
2015
- 2015-10-07 IL IL241962A patent/IL241962B/en active IP Right Grant
- 2015-10-08 PH PH12015502341A patent/PH12015502341B1/en unknown
- 2015-10-18 SA SA515370015A patent/SA515370015B1/ar unknown
-
2017
- 2017-12-06 CY CY20171101288T patent/CY1119754T1/el unknown